IRIS Accounts Production v24.1.0.578 12240396 director 1.11.22 31.10.23 31.10.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122403962022-10-31122403962023-10-31122403962022-11-012023-10-31122403962021-10-31122403962021-11-012022-10-31122403962022-10-3112240396ns15:EnglandWales2022-11-012023-10-3112240396ns14:PoundSterling2022-11-012023-10-3112240396ns10:Director12022-11-012023-10-3112240396ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3112240396ns10:Micro-entities2022-11-012023-10-3112240396ns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3112240396ns10:FullAccounts2022-11-012023-10-3112240396ns10:RegisteredOffice2022-11-012023-10-3112240396ns5:CurrentFinancialInstruments2023-10-3112240396ns5:CurrentFinancialInstruments2022-10-31122403961ns10:Director12022-10-31122403961ns10:Director12021-10-31122403961ns10:Director12022-11-012023-10-31122403961ns10:Director12021-11-012022-10-31122403961ns10:Director12023-10-31122403961ns10:Director12022-10-31
REGISTERED NUMBER: 12240396 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

Global Pharma Qa Limited

Global Pharma Qa Limited (by shares) (Registered number: 12240396)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2


Global Pharma Qa Limited (by shares)

Company Information
for the Year Ended 31 October 2023







DIRECTOR: Mrs O Galperin





REGISTERED OFFICE: 23 Henbury Rise
Corfe Mullen
Wimbourne
Dorset
BH21 3TE





REGISTERED NUMBER: 12240396 (England and Wales)






Global Pharma Qa Limited (by shares) (Registered number: 12240396)

Balance Sheet
31 October 2023

31.10.23 31.10.22
£    £    £    £   
FIXED ASSETS 598 1,986

CURRENT ASSETS 101,800 142,496

CREDITORS
Amounts falling due within one year (26,419 ) (34,966 )
NET CURRENT ASSETS 75,381 107,530
TOTAL ASSETS LESS CURRENT
LIABILITIES

75,979

109,516

CAPITAL AND RESERVES 75,979 109,516

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2022 - 2 ) .

2. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2023 and 31 October 2022:

31.10.23 31.10.22
£    £   
Mrs O Galperin
Balance outstanding at start of year - -
Amounts advanced 28,835 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 28,835 -



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Global Pharma Qa Limited (by shares) (Registered number: 12240396)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 13 February 2024 and were signed by:





Mrs O Galperin - Director